OCUL logo
Ocular Therapeutix, Inc.(OCUL)
Last print unknown agoAbout this dataData status
$6.29▼-0.58 (-8.44%)Stale · unknown oldEarnings · Nov 3

OCUL EBITDA Margin

-546.73%TTM

Period ending:

OCUL FY EBITDA Margin%
OCUL FY EBITDA Margin15980.93%-149095.10%
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

OCUL ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Ocular Therapeutix Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-481.9887%
-276.4198%
-113.6406%
-120.2218%
5.8338%
-839.4817%
-1,839.1531%
-2,811.7085%
-3,113.3125%
-2,233.2803%
-2,129.7143%
-3,495.0777%
0%
-133,120%

Compare ebitda margin

All OCUL financial metrics · OCUL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.